Teachers Advisors’s CorMedix CRMD Stock Holding History

Teachers Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-11,071	Closed	-$147K	–	3130
2016 Q1	$147K	Hold	11,071	–	–	﹤0.01%	2870
2015 Q4	$112K	Buy	11,071 +2,041	+23%	+$23.5K	﹤0.01%	3005
2015 Q3	$90K	Hold	9,030	–	–	﹤0.01%	3020
2015 Q2	$175K	Buy	+9,030	New	+$310K	﹤0.01%	3002

Other funds holding CRMD

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

GLRA

Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Teachers Advisors's CRMD Position: Q2 2016 in Review

Teachers Advisors sold out of CorMedix (CRMD) in Q2 2016, closing a stake of 11,071 shares — an estimated $147K sold.

Teachers Advisors first reported a position in CRMD in Q2 2015 and held it in 4 quarters. The position peaked at $175K in Q2 2015. 47 funds tracked by Wall St. Rank hold CRMD as of Q2 2016.

Teachers Advisors reported no remaining CorMedix position as of Q2 2016 after selling out during the quarter.
Teachers Advisors sold 11,071 CorMedix shares in Q2 2016, an estimated $147K.
Teachers Advisors first reported a position in CorMedix in Q2 2015 and held it in 4 quarters.
Teachers Advisors's CorMedix position peaked at $175K in Q2 2015.
47 funds tracked by Wall St. Rank held CorMedix as of Q2 2016.

Based on Teachers Advisors's 13F filing for Q2 2016, filed 11 Aug 2016.